Senya Pharmaceuticals Inc. has patented thyroid hormone receptor beta (TR-β) agonists reported to be useful for the treatment of dyslipidemia, hypercholesterolemia, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) and liver disease.